谱系追踪揭示了免疫检查点阻断期间肿瘤特异性 T 细胞的克隆祖细胞和长期持久性。
Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade.
机构信息
Department of Pathology, Stanford University, Stanford, CA, USA; Immunology Program, Stanford University, Stanford, CA, USA.
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
出版信息
Cancer Cell. 2023 Apr 10;41(4):776-790.e7. doi: 10.1016/j.ccell.2023.03.009. Epub 2023 Mar 30.
Paired single-cell RNA and T cell receptor sequencing (scRNA/TCR-seq) has allowed for enhanced resolution of clonal T cell dynamics in cancer. Here, we report a scRNA/TCR-seq analysis of 187,650 T cells from 31 tissue regions, including tumor, adjacent normal tissues, and lymph nodes (LN), from three patients with non-small cell lung cancer after immune checkpoint blockade (ICB). Regions with viable cancer cells are enriched for exhausted CD8 T cells, regulatory CD4 T cells (Treg), and follicular helper CD4 T cells (TFH). Tracking T cell clonotypes across tissues, combined with neoantigen specificity assays, reveals that TFH and tumor-specific exhausted CD8 T cells are clonally linked to TCF7SELL progenitors in tumor draining LNs, and progressive exhaustion trajectories of CD8 T, Treg, and TFH cells with proximity to the tumor microenvironment. Finally, longitudinal tracking of tumor-specific CD8 and CD4 T cell clones reveals persistence in the peripheral blood for years after ICB therapy.
配对的单细胞 RNA 和 T 细胞受体测序 (scRNA/TCR-seq) 提高了癌症中克隆 T 细胞动力学的分辨率。在这里,我们报告了对 3 名非小细胞肺癌患者在免疫检查点阻断 (ICB) 后来自 31 个组织区域(包括肿瘤、相邻正常组织和淋巴结 [LN])的 187,650 个 T 细胞的 scRNA/TCR-seq 分析。有存活癌细胞的区域富含耗竭的 CD8 T 细胞、调节性 CD4 T 细胞 (Treg) 和滤泡辅助性 CD4 T 细胞 (TFH)。跨组织追踪 T 细胞克隆型,结合新抗原特异性测定,表明 TFH 和肿瘤特异性耗竭的 CD8 T 细胞与肿瘤引流淋巴结中 TCF7SELL 祖细胞在克隆上相关,并且 CD8 T、Treg 和 TFH 细胞的进行性耗竭轨迹与肿瘤微环境接近。最后,对肿瘤特异性 CD8 和 CD4 T 细胞克隆的纵向追踪显示,在 ICB 治疗后多年,它们在外周血中持续存在。
相似文献
Cancer Immunol Immunother. 2020-6-26
引用本文的文献
Front Immunol. 2025-8-12
bioRxiv. 2025-7-21
Chin Med J (Engl). 2025-9-5
Cell Mol Immunol. 2025-7-10
Theranostics. 2025-6-9
本文引用的文献
J Clin Invest. 2022-6-15
Science. 2021-12-17